1. Cell Biology

Metabolic flexibility via mitochondrial BCAA carrier SLC25A44 is required for optimal fever

  1. Takeshi Yoneshiro
  2. Naoya Kataoka
  3. Jacquelyn M Walejko
  4. Kenji Ikeda
  5. Zachary Brown
  6. Momoko Yoneshiro
  7. Scott B Crown
  8. Tsuyoshi Osawa
  9. Juro Sakai
  10. Robert W McGarrah
  11. Phillip J White
  12. Kazuhiro Nakamura
  13. Shingo Kajimura  Is a corresponding author
  1. University of Tokyo, Japan
  2. Nagoya University Graduate School of Medicine, Japan
  3. Duke University School of Medicine, United States
  4. Tokyo Medical and Dental University, Japan
  5. University of California, San Francisco, United States
  6. The University of Tokyo, Japan
  7. Beth Israel Deaconess Medical Center, United States
https://doi.org/10.7554/eLife.66865
Share this article
Cite this article
  1. Takeshi Yoneshiro
  2. Naoya Kataoka
  3. Jacquelyn M Walejko
  4. Kenji Ikeda
  5. Zachary Brown
  6. Momoko Yoneshiro
  7. Scott B Crown
  8. Tsuyoshi Osawa
  9. Juro Sakai
  10. Robert W McGarrah
  11. Phillip J White
  12. Kazuhiro Nakamura
  13. Shingo Kajimura
(2021)
Metabolic flexibility via mitochondrial BCAA carrier SLC25A44 is required for optimal fever
eLife 10:e66865.
https://doi.org/10.7554/eLife.66865
  2. Download BibTeX
  3. Download .RIS

Abstract

Importing necessary metabolites into the mitochondrial matrix is a crucial step of fuel choice during stress adaptation. Branched chain-amino acids (BCAA) are essential amino acids needed for anabolic processes, but they are also imported into the mitochondria for catabolic reactions. What controls the distinct subcellular BCAA utilization during stress adaptation is insufficiently understood. The present study reports the role of SLC25A44, a recently identified mitochondrial BCAA carrier (MBC), in the regulation of mitochondrial BCAA catabolism and adaptive response to fever in rodents. We found that mitochondrial BCAA oxidation in brown adipose tissue (BAT) is significantly enhanced during fever in response to the pyrogenic mediator prostaglandin E2 (PGE2) and psychological stress in mice and rats. Genetic deletion of MBC in a BAT-specific manner blunts mitochondrial BCAA oxidation and non-shivering thermogenesis following intracerebroventricular PGE2 administration. At a cellular level, MBC is required for mitochondrial BCAA deamination as well as the synthesis of mitochondrial amino acids and TCA intermediates. Together, these results illuminate the role of MBC as a determinant of metabolic flexibility to mitochondrial BCAA catabolism and optimal febrile responses. This study also offers an opportunity to control fever by rewiring the subcellular BCAA fate.

Data availability

All data generated or analyzed during this study are included in the manuscript as source data files.

The following previously published data sets were used

Article and author information

Author details

  1. Takeshi Yoneshiro

    Research Center for Advanced Science and Technology, University of Tokyo, Tokyo, Japan
    Competing interests
    The authors declare that no competing interests exist.

  2. Naoya Kataoka

    Department of Integrative Physiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Competing interests
    The authors declare that no competing interests exist.

  3. Jacquelyn M Walejko

    Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, United States
    Competing interests
    The authors declare that no competing interests exist.

  4. Kenji Ikeda

    Department of Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University, Tokyo, Japan
    Competing interests
    The authors declare that no competing interests exist.

  5. Zachary Brown

    Diabetes Center, University of California, San Francisco, San Francisco, United States
    Competing interests
    The authors declare that no competing interests exist.

  6. Momoko Yoneshiro

    Research Center for Advanced Science and Technology, University of Tokyo, Tokyo, Japan
    Competing interests
    The authors declare that no competing interests exist.

  7. Scott B Crown

    Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, United States
    Competing interests
    The authors declare that no competing interests exist.

  8. Tsuyoshi Osawa

    Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan
    Competing interests
    The authors declare that no competing interests exist.

  9. Juro Sakai

    Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, Japan
    Competing interests
    The authors declare that no competing interests exist.

  10. Robert W McGarrah

    Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, United States
    Competing interests
    The authors declare that no competing interests exist.

  11. Phillip J White

    Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, United States
    Competing interests
    The authors declare that no competing interests exist.

  12. Kazuhiro Nakamura

    Department of Integrative Physiology, Nagoya University Graduate School of Medicine, Nagoya, Japan
    Competing interests
    The authors declare that no competing interests exist.

  13. Shingo Kajimura

    Endocrinology, Diabetes & Metabolism, Beth Israel Deaconess Medical Center, Boston, United States
    For correspondence
    skajimur@bidmc.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0672-5910

Funding

National Institute of Diabetes and Digestive and Kidney Diseases (DK097441)

  • Shingo Kajimura

MEXT KAKENHI (15H05932,15K21744)

  • Naoya Kataoka

MEXT KAKENHI (20H03418)

  • Naoya Kataoka

MEXT KAKENHI (19K06954)

  • Kazuhiro Nakamura

AMED (JP21gm5010002s0305)

  • Kazuhiro Nakamura

JST Moonshot R&D (JPMJMS2023)

  • Kazuhiro Nakamura

National Institute of Diabetes and Digestive and Kidney Diseases (DK126160)

  • Shingo Kajimura

National Institute of Diabetes and Digestive and Kidney Diseases (DK125281)

  • Shingo Kajimura

National Institute of Diabetes and Digestive and Kidney Diseases (DK127575)

  • Shingo Kajimura

The Edward Mallinckrodt, Jr. Foundation

  • Shingo Kajimura

National Heart and Lung Institute (5K08HL13527)

  • Robert W McGarrah

National Heart and Lung Institute (F32HL137398)

  • Scott B Crown

American Diabetes Association (1-16-INI-17)

  • Phillip J White

MEXT KAKENHI (19K06954)

  • Kazuhiro Nakamura

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Ralph J DeBerardinis, UT Southwestern Medical Center, United States

Ethics

Animal experimentation: All the animal experiments were performed following the guidelines by the UCSF Institutional Animal Care and Use Committee or by the Nagoya University Animal Experiment Committee. The protocols were approved by the committees by the Committee on the Ethics of Animal Experiments of UCSF (AN165833) and Nagoya University. All surgery was performed under anesthesia, and every effort was made to minimize suffering.

Version history

  1. Received: January 25, 2021
  2. Accepted: May 2, 2021
  3. Accepted Manuscript published: May 4, 2021 (version 1)
  4. Version of Record published: May 20, 2021 (version 2)

Copyright

© 2021, Yoneshiro et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,456
    Page views
  • 429
    Downloads
  • 12
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Takeshi Yoneshiro
  2. Naoya Kataoka
  3. Jacquelyn M Walejko
  4. Kenji Ikeda
  5. Zachary Brown
  6. Momoko Yoneshiro
  7. Scott B Crown
  8. Tsuyoshi Osawa
  9. Juro Sakai
  10. Robert W McGarrah
  11. Phillip J White
  12. Kazuhiro Nakamura
  13. Shingo Kajimura
(2021)
Metabolic flexibility via mitochondrial BCAA carrier SLC25A44 is required for optimal fever
eLife 10:e66865.
https://doi.org/10.7554/eLife.66865

Share this article

https://doi.org/10.7554/eLife.66865

Categories and tags

Research organism

Further reading

    1. Cell Biology

    Continuous endosomes form functional subdomains and orchestrate rapid membrane trafficking in trypanosomes

    Fabian Link, Alyssa Borges ... Markus Engstler
    Research Article

    Endocytosis is a common process observed in most eukaryotic cells, although its complexity varies among different organisms. In Trypanosoma brucei, the endocytic machinery is under special selective pressure because rapid membrane recycling is essential for immune evasion. This unicellular parasite effectively removes host antibodies from its cell surface through hydrodynamic drag and fast endocytic internalization. The entire process of membrane recycling occurs exclusively through the flagellar pocket, an extracellular organelle situated at the posterior pole of the spindle-shaped cell. The high-speed dynamics of membrane flux in trypanosomes do not seem compatible with the conventional concept of distinct compartments for early endosomes (EE), late endosomes (LE), and recycling endosomes (RE). To investigate the underlying structural basis for the remarkably fast membrane traffic in trypanosomes, we employed advanced techniques in light and electron microscopy to examine the three-dimensional architecture of the endosomal system. Our findings reveal that the endosomal system in trypanosomes exhibits a remarkably intricate structure. Instead of being compartmentalized, it constitutes a continuous membrane system, with specific functions of the endosome segregated into membrane subdomains enriched with classical markers for EE, LE, and RE. These membrane subdomains can partly overlap or are interspersed with areas that are negative for endosomal markers. This continuous endosome allows fast membrane flux by facilitated diffusion that is not slowed by multiple fission and fusion events.

    1. Cell Biology
    2. Neuroscience

    Tissue-specific O-GlcNAcylation profiling identifies substrates in translational machinery in Drosophila mushroom body contributing to olfactory learning

    Haibin Yu, Dandan Liu ... Kai Yuan
    Research Article

    O-GlcNAcylation is a dynamic post-translational modification that diversifies the proteome. Its dysregulation is associated with neurological disorders that impair cognitive function, and yet identification of phenotype-relevant candidate substrates in a brain-region specific manner remains unfeasible. By combining an O-GlcNAc binding activity derived from Clostridium perfringens OGA (CpOGA) with TurboID proximity labeling in Drosophila, we developed an O-GlcNAcylation profiling tool that translates O-GlcNAc modification into biotin conjugation for tissue-specific candidate substrates enrichment. We mapped the O-GlcNAc interactome in major brain regions of Drosophila and found that components of the translational machinery, particularly ribosomal subunits, were abundantly O-GlcNAcylated in the mushroom body of Drosophila brain. Hypo-O-GlcNAcylation induced by ectopic expression of active CpOGA in the mushroom body decreased local translational activity, leading to olfactory learning deficits that could be rescued by dMyc overexpression-induced increase of protein synthesis. Our study provides a useful tool for future dissection of tissue-specific functions of O-GlcNAcylation in Drosophila, and suggests a possibility that O-GlcNAcylation impacts cognitive function via regulating regional translational activity in the brain.

    1. Cancer Biology
    2. Cell Biology

    Early recovery of proteasome activity in cells pulse-treated with proteasome inhibitors is independent of DDI2

    Ibtisam Ibtisam, Alexei F Kisselev
    Short Report

    Rapid recovery of proteasome activity may contribute to intrinsic and acquired resistance to FDA-approved proteasome inhibitors. Previous studies have demonstrated that the expression of proteasome genes in cells treated with sub-lethal concentrations of proteasome inhibitors is upregulated by the transcription factor Nrf1 (NFE2L1), which is activated by a DDI2 protease. Here, we demonstrate that the recovery of proteasome activity is DDI2-independent and occurs before transcription of proteasomal genes is upregulated but requires protein translation. Thus, mammalian cells possess an additional DDI2 and transcription-independent pathway for the rapid recovery of proteasome activity after proteasome inhibition.